drugset / Trial / NCT00002246

A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex

NCT00002246

Phase 3 Completed 20 enrolled Bristol-Myers Squibb
Treatment

Summary

The purpose of this study is to see if adding stavudine (d4T) to anti-HIV drug regimens (with or without zidovudine, ZDV) can improve symptoms of AIDS Dementia Complex (ADC, problems involving the brain or spinal cord) in HIV-positive patients.

Timeline

Start
1997-10
Primary completion
1999-03
Completion
1999-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Stavudine Other / unclassified